XNCR

Xencor, Inc. NGM · XNCR

$17.47 +2.52 (+16.86%)

Blow-off · +2.53σ Hot zone Grade C

+ Compare Open in Sniper

Valuation

Market cap $1.3B

P/E (ttm) —

Forward P/E -4.9

Beta (5y) 0.86

Shares out 74.1M

Div yield —

Profitability & returns

ROE -29.8%

Net margin -177.1%

FCF margin -79.0%

Debt / equity 0.34

Trading information

Last price $17.47

Day range $14.60 – $17.67

52-wk range $10.38 – $17.67

Avg volume 0.8M

RSI (2) 96.7

Trend zone Blow-off

52-week range · today's price

$10.38$17.67

Company

Sector Healthcare

Industry Biotechnology

Exchange NGM

Next earnings 2026-08-05

Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered antibodies for the treatment of cancer and autoimmune diseases. The company provides Ultomiris to treat patients with atypical hemolytic uremic syndrome, generalized myasthenia gravis, and neuromyelitis optica spectrum disororder; and Monjuvi for the treatment of patients with relapsed or refractory diffus…